Navigation Links
5th European Breast Cancer Conference Talks about Everything from Patient to Oncologist

The 5th European breast cancer conference (EBCC-5) had doctors, nurses, patients and advocates to support breast cancer research and improve patient care//. Breast cancer is the most common cancer among European women. But as of now the survival rates are improving.

The event was conducted by three organizations in collaboration with each other. The European Breast Cancer Coalition, The European Organization for Research and Treatment of Cancer (EORTC) and the European Society of Mastology (EUSOMA) are the trio organizations.

This event saw the views of all the major breast cancer advocacy groups and institutions in one arena. It manly discussed about the existing treatment facilities and how to improve it.

According to Dr A. Costa, the chair of the European breast cancer Conference, and Dr S. Kyriakides, co-chair it was said that at least one in ten will experience breast cancer. This is a major public health priority. The main aim is to improve breast cancer care for all those patients across Europe.

The various goals set by the conference are as follows: 1. To improve the number and quality of European breast cancer screening programmes. 2. To increase the funds allocated to support breast cancer research. 3. In detail and accurate breast cancer staging system to be designed to improve prediction of outcome. 4. To clearly define metastatic breast cancer guidelines. 5. Increase the number of breast care nurses to improve patient care and quality of life. 6. Standardization and accreditation is necessary to ensure the breast units meet guideline requirements. 7. Give recognition and encouragement to the role played by charities in breast cancer research.


'"/>




Page: 1

Related medicine news :

1. Lung Cancer Deaths Declining In Men But Not Women In European Countries
2. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
3. European Countries To Fund $4 Billion For Vaccination For Poor Children’
4. Nanotechnology Revolution To Be Spearheaded By European Union
5. Detection of Weak strains of bird flu virus – Target of European Unio
6. Europe On High Bird Flu Alert: European Commission
7. Slovenia, Bulgaria, Greece Face Bird Flu Threat: European Union
8. Heart Brakes: Hearts in European Union Invite Health Attention
9. European Union: Poultry producers Need Aid to Survive Bird flu crisis
10. Control And Prevention Of Three Diseases To Be Discussed: European Commission
11. Vitamin D Deficiency On Rise Among Europeans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: